Insider Transactions in Q1 2023 at Zentalis Pharmaceuticals, Inc. (ZNTL)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2023
|
Iris Roth Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
52,500
+50.0%
|
-
|
|
Feb 14
2023
|
Epperly Melissa B, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,227
-1.32%
|
$99,313
$19.98 P/Share
|
|
Feb 14
2023
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
6,500
-0.75%
|
$123,500
$19.98 P/Share
|
|
Feb 14
2023
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
8,501
-1.7%
|
$161,519
$19.96 P/Share
|
|
Feb 13
2023
|
Epperly Melissa B, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,624
-0.66%
|
$52,480
$20.42 P/Share
|
|
Feb 13
2023
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,807
-0.43%
|
$76,140
$20.42 P/Share
|
|
Feb 13
2023
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
3,332
-0.66%
|
$66,640
$20.42 P/Share
|
|
Feb 06
2023
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
10,000
-0.98%
|
$220,000
$22.63 P/Share
|
|
Feb 01
2023
|
Carrie Brownstein Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,313
+12.3%
|
-
|
|
Feb 01
2023
|
Andrea Paul Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,783
+50.0%
|
-
|
|
Feb 01
2023
|
Epperly Melissa B, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
101,957
+20.32%
|
-
|
|
Feb 01
2023
|
Kimberly Blackwell Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
244,800
+49.49%
|
-
|
|
Feb 01
2023
|
Cam Gallagher President, Interim CFO |
BUY
Grant, award, or other acquisition
|
Direct |
161,092
+23.89%
|
-
|
|
Feb 01
2023
|
Kevin D. Bunker Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
91,354
+9.45%
|
-
|
|
Jan 17
2023
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
10,000
-1.38%
|
$240,000
$24.49 P/Share
|
|
Jan 05
2023
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
10,000
-1.35%
|
$210,000
$21.24 P/Share
|